Miltefosine Pregnancy and Breastfeeding Warnings

Miltefosine is also known as: Impavido

Miltefosine Pregnancy Warnings

Animal studies have revealed embryo-fetal toxicity including death and teratogenicity. Animal studies, have also shown evidence of impaired fertility and reduced viable sperm counts. There are no controlled data in human pregnancy.

This drug is contraindicated in pregnant women. US FDA pregnancy category: D Comments: Use of adequate methods of contraception should be advised during therapy and for 5 months after therapy. US FDA pregnancy category D: There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Miltefosine Breastfeeding Warnings

A decision should be made whether to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother. Breastfeeding should be avoided for 5 months after therapy. Excreted into human milk: Unknown Excreted into animal milk: Data not available

See references

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.